Literature DB >> 24815946

p-Coumaric acid and ursolic acid from Corni fructus attenuated β-amyloid(25-35)-induced toxicity through regulation of the NF-κB signaling pathway in PC12 cells.

Jeong-Hyun Yoon1, Kumju Youn, Chi-Tang Ho, Mukund V Karwe, Woo-Sik Jeong, Mira Jun.   

Abstract

Neuroinflammatory responses induced by amyloid-beta peptide (Aβ) are important causes in the pathogenesis of Alzheimer's disease (AD). Blockade of Aβ has emerged as a possible therapeutic approach to control the onset of AD. This study investigated the neuroprotective effects and molecular mechanisms of p-coumaric acid (p-CA) and ursolic acid (UA) from Corni fructus against Aβ(25-35)-induced toxicity in PC12 cells. p-CA and UA significantly inhibited the expression of iNOS and COX-2 in Aβ(25-35)-injured PC12 cells. Blockade of nuclear translocation of the p65 subunit of nuclear factor κB (NF-κB) and phosphorylation of IκB-α was also observed after p-CA and UA treatment. For the upstream kinases, UA exclusively reduced ERK1/2, p-38, and JNK phosphorylation, but p-CA suppressed ERK1/2 and JNK phosphorylation. Both compounds comprehensively inhibited NF-κB activity, but possibly with different upstream pathways. The results provide new insight into the pharmacological modes of p-CA and UA and their potential therapeutic application to AD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24815946     DOI: 10.1021/jf501314g

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  26 in total

Review 1.  Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases.

Authors:  Ana B Ramos-Hryb; Francis L Pazini; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

2.  Ursolic acid abrogates depressive-like behavior and hippocampal pro-apoptotic imbalance induced by chronic unpredictable stress.

Authors:  André R S Colla; Francis L Pazini; Vicente Lieberknecht; Anderson Camargo; Ana Lúcia S Rodrigues
Journal:  Metab Brain Dis       Date:  2021-01-04       Impact factor: 3.584

3.  p-Coumaric acid protects against D-galactose induced neurotoxicity by attenuating neuroinflammation and apoptosis in mice brain.

Authors:  Pratibha Atul Daroi; Shrikant Ninaji Dhage; Archana Ramesh Juvekar
Journal:  Metab Brain Dis       Date:  2022-08-01       Impact factor: 3.655

4.  Sarcococca saligna ameliorated D-galactose induced neurodegeneration through repression of neurodegenerative and oxidative stress biomarkers.

Authors:  Uzma Saleem; Zunera Chauhdary; Sumera Islam; Aimen Zafar; Rana O Khayat; Norah A Althobaiti; Ghulam Mujtaba Shah; Mohammed Alqarni; Muhammad Ajmal Shah
Journal:  Metab Brain Dis       Date:  2022-07-26       Impact factor: 3.655

5.  Neuroprotective effects of phenylethanoid glycosides in an in vitro model of Alzheimer's disease.

Authors:  Jianhua Yang; Bowei Ju; Yao Yan; Huanhuan Xu; Shanshan Wu; Dandan Zhu; Dandan Cao; Junping Hu
Journal:  Exp Ther Med       Date:  2017-03-22       Impact factor: 2.447

Review 6.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

7.  Neuroprotective effect of p-coumaric acid in mice with cerebral ischemia reperfusion injuries.

Authors:  Romgase Sakamula; Wachiryah Thong-Asa
Journal:  Metab Brain Dis       Date:  2018-01-17       Impact factor: 3.584

8.  Gallic acid and p-coumaric acid attenuate type 2 diabetes-induced neurodegeneration in rats.

Authors:  Adel Abdel-Moneim; Ahmed I Yousef; Sanaa M Abd El-Twab; Eman S Abdel Reheim; Mohamed B Ashour
Journal:  Metab Brain Dis       Date:  2017-06-02       Impact factor: 3.584

9.  Antioxidant, antimicrobial and neuroprotective effects of Octaviania asterosperma in vitro.

Authors:  Mustafa Sevindik; Hasan Akgul; Zeliha Selamoglu; Nady Braidy
Journal:  Mycology       Date:  2020-12-02

10.  Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injury.

Authors:  Yanzhe Wang; Zhiyi He; Shumin Deng
Journal:  Drug Des Devel Ther       Date:  2016-05-17       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.